961
Views
8
CrossRef citations to date
0
Altmetric
Bedside to Bench Report

Double amplifications of CDK4 and MDM2 in a gastric inflammatory myofibroblastic tumor mimicking cancer with local invasion of the spleen and diaphragm

, , , , , , , & show all
Pages 967-972 | Received 20 Feb 2018, Accepted 20 May 2018, Published online: 25 Sep 2018

References

  • Albayrak F, Dursun H, Albayrak Y, Altas S, Uyanik A, Yildirm R. Inflammatory myofibroblastic tumor of the stomach in an adult woman: a rare intermittent cause of gastric outlet obstruction. Tumori. 2010;96(3):492–495.
  • Goldin SB, Osborne D, Paidas C, Iannello J, Gilbert-Barness E, Karl R, Wilsey MJ Jr. Inflammatory myofibroblastic tumor of the midesophagus. Fetal Pediatr Pathol. 2007;26(5–6):243–254. doi:10.1080/15513810801893421.
  • Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol. 2007;31(4):509–520. doi:10.1097/01.pas.0000213393.57322.c7.
  • Coindre JM. [Histologic classification of soft tissue tumors (WHO, 1994)]. Ann Pathol. 1994;14(6):426–427.
  • Coffin CM, Humphrey PA, Dehner LP. Extrapulmonary inflammatory myofibroblastic tumor: a clinical and pathological survey. Semin Diagn Pathol. 1998;15(2):85–101.
  • Qiu JF, Shi YJ, Fang L, Wang HF, Zhang MC. High fever as an initial symptom of primary gastric inflammatory myofibroblastic tumor in an adult woman. Int J Clin Exp Med. 2014;7(5):1468–1473.
  • Jadhav M, Harvi R, Patil R, Kittur S. Inflammatory Myofibroblastic Tumor of the Stomach Presenting as an Exophytic Mass - A Diagnostic Dilemma. Turk Patoloji Derg. 2017;01388. [E-pub ahead of print.]
  • Shi H, Wei L, Sun L, Guo A. Primary gastric inflammatory myofibroblastic tumor: a clinicopathologic and immunohistochemical study of 5 cases. Pathol Res Pract. 2010;206(5):287–291. doi:10.1016/j.prp.2009.09.002.
  • Chen WC, Jiang ZY, Zhou F, Wu ZR, Jiang GX, Zhang BY, Cao LP. A large inflammatory myofibroblastic tumor involving both stomach and spleen: A case report and review of the literature. Oncol Lett. 2015;9(2):811–815. doi:10.3892/ol.2014.2761.
  • Zhao Z, Verma V, Zhang M. Anaplastic lymphoma kinase: role in cancer and therapy perspective. Cancer Biol Ther. 2015;16(12):1691–1701. doi:10.1080/15384047.2015.1095407.
  • Hornick JL, Sholl LM, Dal Cin P, Childress MA, Lovly CM. Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors. Mod Pathol. 2015;28(5):732–739. doi:10.1038/modpathol.2014.165.
  • Ricciotti RW, Baraff AJ, Jour G, Kyriss M, Wu Y, Liu Y, Li SC, Hoch B, Liu YJ. High amplification levels of MDM2 and CDK4 correlate with poor outcome in patients with dedifferentiated liposarcoma: A cytogenomic microarray analysis of 47 cases. Cancer Genet. 2017; 218-219: 69–80. doi:10.1016/j.cancergen.2017.09.005.
  • Jo VY, Fletcher CD. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathol. 2014;46(2):95–104. doi:10.1097/PAT.0000000000000050.
  • Kim KA, Park CM, Lee JH, Cha SH, Park SW, Hong SJ, Seol HY, Cha IH, Mok YJ, Kim YS. Inflammatory myofibroblastic tumor of the stomach with peritoneal dissemination in a young adult: imaging findings. Abdom Imaging. 2004;29(1):9–11. doi:10.1007/s00261-003-0085-z.
  • Makhlouf HR, Sobin LH. Inflammatory myofibroblastic tumors (inflammatory pseudotumors) of the gastrointestinal tract: how closely are they related to inflammatory fibroid polyps? Hum Pathol. 2002;33(3):307–315.
  • Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol. 2000;13(10):1134–1142. doi:10.1038/modpathol.3880210.
  • Lovly CM, Gupta A, Lipson D, Otto G, Brennan T, Chung CT, Borinstein SC, Ross JS, Stephens PJ, Miller VA, et al. Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions. Cancer Discov. 2014;4(9):889–895. doi:10.1158/2159-8290.CD-14-0377.
  • Debelenko LV, Arthur DC, Pack SD, Helman LJ, Schrump DS, Tsokos M. Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor. Lab Invest. 2003; (9): 1255–1265. doi:10.1097/01.LAB.0000088856.49388.EA.
  • Brooks JK, Nikitakis NG, Frankel BF, Papadimitriou JC, Sauk JJ. Oral inflammatory myofibroblastic tumor demonstrating ALK, p53, MDM2, CDK4, pRb, and Ki-6 immunoreactivity in an elderly patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99(6):716–726. doi:10.1016/j.tripleo.2004.11.023.
  • Nikitakis NG, Drachenberg CB, Papadimitriou JC. MDM2 and CDK4 Expression in Carcinosarcoma of the Esophagus: comparison with Squamous Cell Carcinoma and Review of the Literature. Exp Mol Pathol. 2002;73(3):198–208. doi:10.1006/exmp.2002.2465.
  • Ashcroft M, Vousden KH. Regulation of p53 stability. Oncogene. 1999;18(53):7637–7643. doi:10.1038/sj.onc.1203012.
  • Lundgren K, Montes De Oca Luna R, McNeill YB, Emerick EP, Spencer B, Barfield CR, Lozano G, Rosenberg MP, Ca F. Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53. Genes Dev. 1997;11(6):714–725.
  • Asghar U, Witkiewicz AK, Turner NC, Knudsen ES. The history and future of targeting cyclin-dependent kinases in cancer therapy. Nat Rev Drug Discov. 2015;14(2):130–146. doi:10.1038/nrd4504.
  • Witkiewicz AK, Knudsen KE, Dicker AP, Knudsen ES. The mining of p16ink4a expression in tumors. Cell Cycle. 2011;10(15):2497–2503. doi:10.4161/cc.10.17.17068.
  • Laroche-Clary A, Chaire V, Algeo MP, Derieppe MA, Loarer FL, Italiano A. Combined atargeting of MDM2 and CDK4 is synergistic in dedifferentiated liposarcomas. J Hematol Oncol. 2017;10(1):123. doi:10.1186/s13045-017-0482-3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.